130 related articles for article (PubMed ID: 7036497)
21. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
[TBL] [Abstract][Full Text] [Related]
23. Myocardial ischemia: platelet and thromboxane concentrations in cardiac lymph and the effects of ibuprofen and prostacyclin.
Michael LH; Hunt JR; Lewis RM; Entman ML
Circ Res; 1986 Jul; 59(1):49-55. PubMed ID: 3524894
[TBL] [Abstract][Full Text] [Related]
24. Prevention of acquired transient defect in platelet plug formation by infused prostacyclin.
Malpass TW; Hanson SR; Savage B; Hessel EA; Harker LA
Blood; 1981 Apr; 57(4):736-40. PubMed ID: 7008866
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of platelet preservation with prostanoids during simulated bypass.
Kappa JR; Musial J; Fisher CA; Addonizio VP
J Surg Res; 1987 Jan; 42(1):10-8. PubMed ID: 2433503
[TBL] [Abstract][Full Text] [Related]
26. Treatment of aspiration pneumonia with ibuprofen and prostacyclin.
Utsunomiya T; Krausz MM; Valeri CR; Shepro D; Hechtman HB
Surgery; 1981 Aug; 90(2):170-6. PubMed ID: 7020135
[No Abstract] [Full Text] [Related]
27. [Effect of a PGI2 derivative (op-41483) during extracorporeal circulation].
Matsukura H; Takeda H; Edasawa H; Sakai K; Kawakami T
Kyobu Geka; 1982 Nov; 35(11):876-7. PubMed ID: 6759741
[No Abstract] [Full Text] [Related]
28. Epoprostenol now the focus of numerous clinical trials.
Check WA
JAMA; 1981 Jun; 245(24):2481-3. PubMed ID: 7014954
[No Abstract] [Full Text] [Related]
29. [Platelet sensitivity to prostacyclin in diabetic and nondiabetic patients with atherosclerotic vascular changes: a measure of platelet membrane prostacyclin receptors?].
Klein K; Kaliman J; Sinzinger H; Silberbauer K
Vasa; 1980; 9(2):123-6. PubMed ID: 6256984
[No Abstract] [Full Text] [Related]
30. Epoprostenol for the treatment of increasing oxygenator pressure drop during cardiopulmonary bypass. A case report.
Hjärpe AK; Reinsfelt B
Perfusion; 2018 Apr; 33(3):228-231. PubMed ID: 28872410
[TBL] [Abstract][Full Text] [Related]
31. Prostacyclin and anti-platelet drugs.
J Assoc Physicians India; 1979 Feb; 27(2):149-51. PubMed ID: 389924
[No Abstract] [Full Text] [Related]
32. [Effects of prostaglandin I2 infusion during experimental cardiopulmonary bypass (author's transl)].
Matsukura H; Takeda H; Kawakami T; Tanabe T
Nihon Kyobu Geka Gakkai Zasshi; 1982 Feb; 30(2):164-71. PubMed ID: 7047654
[No Abstract] [Full Text] [Related]
33. Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass.
Zapol WM; Peterson MB; Wonders TR; Kong D; Watkins WD
Trans Am Soc Artif Intern Organs; 1980; 26():556-60. PubMed ID: 7018060
[No Abstract] [Full Text] [Related]
34. Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass.
Carteaux JP; Roux S; Kuhn H; Tschopp T; Colombo V; Hadváry P
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):834-41. PubMed ID: 8231205
[TBL] [Abstract][Full Text] [Related]
35. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.
Ereth MH; Nuttall GA; Clarke SH; Dearani JA; Fiechtner BK; Rishavy CR; Buda DA; Shaw TA; Orszulak TA; Oliver WC
J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):545-50; discussion 539-41. PubMed ID: 11687991
[TBL] [Abstract][Full Text] [Related]
36. Clinical study of blood trauma during perfusion with membrane and bubble oxygenators.
van den Dungen JJ; Karliczek GF; Brenken U; Homan van der Heide JN; Wildevuur CR
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):108-16. PubMed ID: 7054605
[TBL] [Abstract][Full Text] [Related]
37. Failure of surface-modified bypass circuits to improve platelet function during pediatric cardiac surgery.
Kirshbom PM; Miller BE; Spitzer K; Easley KA; Spainhour CE; Kogon BE; Kanter KR
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):675-80. PubMed ID: 16935126
[TBL] [Abstract][Full Text] [Related]
38. The effect of sulfinpyrazone on platelet and pulmonary responses to onset of membrane oxygenator perfusion.
Birek A; Duffin J; Glynn MF; Cooper JD
Trans Am Soc Artif Intern Organs; 1976; 22():94-101. PubMed ID: 951897
[No Abstract] [Full Text] [Related]
39. Evaluation of a new low pressure drop membrane oxygenator.
Mieszala J; Pearson B
Trans Am Soc Artif Intern Organs; 1982; 28():342-9. PubMed ID: 6819672
[No Abstract] [Full Text] [Related]
40. Modulation of cardiovascular function and platelet survival by endogenous prostacyclin released during surgery.
Krausz MM; Utsunomiya T; McIrvine AJ; Allen PD; Levine L; Mannick JA; Shepro D; Hechtman HB
Surgery; 1983 Apr; 93(4):554-9. PubMed ID: 6340233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
